Your session is about to expire
← Back to Search
Arthrocentesis for Knee Osteoarthritis
N/A
Recruiting
Led By Jason Jennings, MD
Research Sponsored by Colorado Joint Replacement
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately pre aspiration (day 0), immediately post aspiration (day 0),optional 7-10 days post aspiration
Awards & highlights
No Placebo-Only Group
Summary
This trial will study the effects of therapeutic joint arthrocentesis in patients with knee effusion associated with degenerative osteoarthritis or symptomatic primary total knee arthroplasty.
Eligible Conditions
- Water on the knee
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately pre aspiration (day 0), immediately post aspiration (day 0),optional 7-10 days post aspiration
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately pre aspiration (day 0), immediately post aspiration (day 0),optional 7-10 days post aspiration
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in quadriceps activation
Secondary study objectives
Bioelectrical Impedance
Change in Pain
Function
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Primary TKAExperimental Treatment1 Intervention
Patients with total knee replacements will participate in this arm.
Group II: Primary OsteoarthritisExperimental Treatment1 Intervention
Patients with native knees and effusions will participate in this arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Arthrocentesis
2017
N/A
~200
Find a Location
Who is running the clinical trial?
Colorado Joint ReplacementLead Sponsor
11 Previous Clinical Trials
3,155 Total Patients Enrolled
Jason Jennings, MDPrincipal Investigator - Colorado Joint Replacement
Porter Adventist Hospital, Select Specialty Hospital-Denver (South Campus)
University Of South Florida College Of Medicine (Medical School)
4 Previous Clinical Trials
255 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a type of arthritis that causes inflammation, such as JIA, RA, or psoriatic arthritis.You have a pre-existing condition affecting your muscles, like stroke, cerebral palsy, multiple sclerosis, or muscular dystrophy.You are experiencing pain in your hip that is causing noticeable discomfort.You have received any kind of invasive or injectable treatment in your knee within the last 6 months, like corticosteroid injections or stem cell therapy.You have fluid buildup in your body due to an injury or another underlying condition.You have active cancer in the specific area being studied.You have a condition that affects your blood clotting ability, such as sickle cell disease or chronic use of blood thinners.You have a pacemaker implanted in your body.
Research Study Groups:
This trial has the following groups:- Group 1: Primary TKA
- Group 2: Primary Osteoarthritis
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger